Latest News

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix’s HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix’s HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

NEW YORK, N.Y., July 15, 2024 – PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's (Nasdaq: SNGX) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte™...

Sanwire Corporation Announces Engagement of PCAOB-Registered Auditor and Accounting Firm in Preparation for Filing Form 10 with the SEC

Sanwire Corporation Announces Engagement of PCAOB-Registered Auditor and Accounting Firm in Preparation for Filing Form 10 with the SEC

Point Roberts, WA, July 15, 2024 - Sanwire Corporation ("Sanwire" or the "Company") (OTC: SNWR), a diversified company with a focus on aggregating technologies within a number of industries, is pleased to announce that it has retained Fruci & Associates II, PLLC...

BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers

BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers

POMPANO BEACH, FL, July 10, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved...